Omar Abdel‐Rahman
A5108043749- Colorectal Cancer Treatments and Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Neuroendocrine Tumor Research Advances
- Lung Cancer Research Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Renal cell carcinoma treatment
- Colorectal Cancer Screening and Detection
- Lung Cancer Diagnosis and Treatment
- Breast Cancer Treatment Studies
- Multiple and Secondary Primary Cancers
- Prostate Cancer Treatment and Research
- Colorectal and Anal Carcinomas
- Liver Disease Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Neuroblastoma Research and Treatments
- Global Cancer Incidence and Screening
- Colorectal Cancer Surgical Treatments
- Thyroid Cancer Diagnosis and Treatment
- Genetic factors in colorectal cancer
- Economic and Financial Impacts of Cancer
University of Alberta
2016-2025
Alberta Cancer Foundation
2023
Ipsen (France)
2022
Bayer (United States)
2022
Eisai (Japan)
2022
Cancer Institute (WIA)
2021-2022
Cleveland Clinic
2021
Ain Shams University
2012-2020
University of Calgary
2018-2019
Institute for Health Metrics and Evaluation
2018
Cancer and other noncommunicable diseases (NCDs) are now widely recognized as a threat to global development. The latest United Nations high-level meeting on NCDs reaffirmed this observation also highlighted the slow progress in 2011 Political Declaration Prevention Control of Noncommunicable Diseases third Sustainable Development Goal. Lack situational analyses, priority setting, budgeting have been identified major obstacles achieving these goals. All common that they require information...
Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department Economics Social Affairs (UNPOP), United States Census Bureau, WHO, as part previous iterations Global Burden Diseases, Injuries, Risk Factors Study (GBD). Previous GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent with numbers deaths GBD. The present iteration GBD, 2017, improves on assessments provides timely experience...
BackgroundEfforts to establish the 2015 baseline and monitor early implementation of UN Sustainable Development Goals (SDGs) highlight both great potential for threats improving health by 2030. To fully deliver on SDG aim “leaving no one behind”, it is increasingly important examine health-related SDGs beyond national-level estimates. As part Global Burden Diseases, Injuries, Risk Factors Study 2017 (GBD 2017), we measured progress 41 52 indicators estimated index 195 countries territories...
BackgroundPopulation estimates underpin demographic and epidemiological research are used to track progress on numerous international indicators of health development. To date, internationally available population fertility, although useful, have not been produced with transparent replicable methods do use standardised mortality. We present single-calendar year single-year age fertility by sex methods.MethodsWe estimated in 195 locations single calendar from 1950 2017 methods. based the...
Pancreatic cancer is the fourth-leading cause of deaths in United States. The silent nature disease and its poor prognosis, need for further research, along with to assess outcomes current approaches necessitate an ongoing evaluation epidemiology mortality-trends this malignancy. Continuous monitoring disease-patterns, on population-levels, may help scientists quality healthcare delivery, boost their understanding diseases' characteristics risk factors, detect gaps whereby research needed....
AIMTo evaluate the prognostic value of site-specific metastases among patients with metastatic pancreatic
Thyroid cancer management is rapidly changing. The identification of actionable biomarkers through both germline and somatic testing are now an integral part directing patient management. However, deficiencies disparities within existing thyroid biomarker test approaches resulting in inconsistent application for care. An expert panel was convened to create consensus algorithms recommendations on patients diagnosed with medullary cancer, non-anaplastic follicular cell-derived or anaplastic...
Background: We the prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma (HCC) patients registered within surveillance, epidemiology and end results (SEER) database.Methods: SEER database (2010–2013) has been queried through SEER*Stat program to determine prognosis advanced HCC according site disease. Survival analysis conducted Kaplan Meier analysis.Results: A total 4396 with stage IV were identified period from 2010–2013 they included into this analysis....